Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action stimulants |
Mechanism TGFB1 stimulants(Transforming growth factor beta 1 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Graft vs Host Disease | Preclinical | Belgium | 14 May 2024 | |
| Graft vs Host Disease | Preclinical | Belgium | 14 May 2024 |






